Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | +0.09% | +0.09% | +2.65% |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 294.7 | 314.5 |
Enterprise Value (EV) 1 | 297.5 | 318.5 |
P/E ratio | 42.9 x | 26.5 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | - | -1,38,11,27,682 x |
FCF Yield | - | -0% |
Price to Book | -16.3 x | -12.8 x |
Nbr of stocks (in thousands) | 28,750 | 28,750 |
Reference price 2 | 10.25 | 10.94 |
Announcement Date | 30/03/23 | 20/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT | - | -0.6851 | -2.032 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -0.003727 | 4.929 | 11.44 |
Net income 1 | -0.003727 | 4.929 | 11.44 |
Net margin | - | - | - |
EPS | - | 0.2390 | 0.4128 |
Free Cash Flow | - | - | -0.2306 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 11/03/22 | 30/03/23 | 20/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.14 | 2.8 | 3.93 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | -0.23 |
ROE (net income / shareholders' equity) | - | -54.7% | -62.6% |
ROA (Net income/ Total Assets) | - | -0.36% | -0.61% |
Assets 1 | - | -1,388 | -1,870 |
Book Value Per Share 2 | 0 | -0.6300 | -0.8600 |
Cash Flow per Share | - | 0.0200 | 0 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 11/03/22 | 30/03/23 | 20/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.65% | 243M | |
+154.80% | 6.04B | |
+2.19% | 982M | |
+41.91% | 872M | |
+26.41% | 853M | |
+2.11% | 664M | |
+5.03% | 620M | |
-.--% | 600M | |
+7.78% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- RENE Stock
- Financials Cartesian Growth Corporation II